Insight into Amyloid Structure Using Chemical Probes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Chemical Biology and Drug Design

• Publication date

  2011-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1747-0285.2011.01110.xPMID 21457473PMCID PMC3097318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transformation of amyloid β(1–40) oligomers into fibrils is characterized by a major change in secondary structure

  2011cited by this paper
• Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level.

  2010cited by this paper
• NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.

  2010cited by this paper
• "Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: design, synthesis, and biological characterization.

  2010cited by this paper
• An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies.

  2010cited by this paper
• A fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates.

  2010cited by this paper
• Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures.

  2010cited by this paper
• A Strategy for Designing a Peptide Probe for Detection of β‐Amyloid Oligomers

  2010cited by this paper
• Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils

  2010cited by this paper
• Quantifying Prefibrillar Amyloids in vitro by Using a “Thioflavin‐Like” Spectroscopic Method

  2010cited by this paper
• Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

  2010cited by this paper
• Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy.

  2010cited by this paper
• Structurally distinct toxicity inhibitors bind at common loci on β‐amyloid fibril

  2010cited by this paper
• Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease.

  2010cited by this paper
• Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

  2010influential reference
• Identifying the bond responsible for the fluorescence modulation in an amyloid fibril sensor.

  2010cited by this paper
• Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status

  2010cited by this paper
• Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer's disease.

  2010cited by this paper
• Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.

  2010cited by this paper
• Highly sensitive amyloid detection enabled by thioflavin T dimers.

  2010cited by this paper
• Ultrafast bond twisting dynamics in amyloid fibril sensor.

  2010cited by this paper
• Amyloid-beta42 oligomer structures from fibrils: a systematic molecular dynamics study.

  2010cited by this paper
• 9,10‐Anthraquinone hinders β‐aggregation: How does a small molecule interfere with Aβ‐peptide amyloid fibrillation?

  2009cited by this paper
• Optical properties of amyloid stained by Congo red: history and mechanisms.

  2009cited by this paper
• Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses.

  2009cited by this paper
• Binding modes of thioflavin-T to the single-layer beta-sheet of the peptide self-assembly mimics.

  2009cited by this paper
• Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange.

  2009cited by this paper
• Push-pull benzothiazole derivatives as probes for detecting beta-amyloid plaques in Alzheimer's brains.

  2009cited by this paper
• Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.

  2009cited by this paper
• Ultrafast torsional dynamics of protein binding dye thioflavin-T in nanoconfined water pool.

  2009cited by this paper
• Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.

  2009cited by this paper
• A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.

  2009cited by this paper
• Synthesis and beta-amyloid binding properties of rhenium 2-phenylbenzothiazoles.

  2009cited by this paper
• The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds

  2009cited by this paper
• Templating molecular arrays in amyloid's cross-beta grooves.

  2009cited by this paper
• Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies.

  2009cited by this paper
• Structural characterization of a soluble amyloid beta-peptide oligomer.

  2009cited by this paper
• Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils.

  2008cited by this paper
• Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: Application to Aβ(1‐40) fibrillogenesis

  2008cited by this paper
• The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and Toxicity*

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?

  2008cited by this paper
• Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Aβ1–40 fibrillogenesis

  2008cited by this paper
• Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

  2008cited by this paper
• Abeta-globulomers are formed independently of the fibril pathway.

  2008cited by this paper
• The binding of thioflavin T and its neutral analog BTA-1 to protofibrils of the Alzheimer's disease Abeta(16-22) peptide probed by molecular dynamics simulations.

  2008influential reference
• Congo red and thioflavin-T analogs detect Abeta oligomers.

  2008cited by this paper
• Physical basis of colors seen in Congo red-stained amyloid in polarized light

  2008cited by this paper
• Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.

  2007cited by this paper
• Characterization of radioiodinated ligand binding to amyloid β plaques

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Congo red and thioflavin‐T analogs detect Aβ oligomers

  2007cited by this paper
• Studies of luminescent conjugated polythiophene derivatives: enhanced spectral discrimination of protein conformational states.

  2007cited by this paper
• Binding mode of Thioflavin T in insulin amyloid fibrils.

  2007cited by this paper
• Branched KLVFF Tetramers Strongly Potentiate Inhibition of β‐Amyloid Aggregation

  2007cited by this paper
• Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.

  2007cited by this paper
• Structure–activity Relationships of Amyloid Beta‐aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility

  2007cited by this paper
• Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid

  2007cited by this paper
• Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations.

  2007influential reference
• Visualization and Classification of Amyloid β Supramolecular Assemblies

  2007cited by this paper
• Visualization and classification of amyloid beta supramolecular assemblies.

  2007cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

  2007cited by this paper
• Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications.

  2007cited by this paper
• Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

  2007cited by this paper
• The Solvent Protection of Alzheimer Amyloid-β-(1–42) Fibrils as Determined by Solution NMR Spectroscopy*

  2006cited by this paper
• Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.

  2006cited by this paper
• Scanning Cysteine Mutagenesis Analysis of Aβ-(1-40) Amyloid Fibrils*

  2006cited by this paper
• Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.

  2006cited by this paper
• Atomic-level description of amyloid beta-dimer formation.

  2006cited by this paper
• Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease

  2006cited by this paper
• High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers

  2006cited by this paper
• A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid‐β oligomeric complexes

  2006cited by this paper
• Atomic-Level Description of Amyloid β-Dimer Formation

  2006cited by this paper
• High-resolution atomic force microscopy of soluble Abeta42 oligomers.

  2006cited by this paper
• Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

  2005cited by this paper
• Chiral bias of amyloid fibrils revealed by the twisted conformation of Thioflavin T: An induced circular dichroism/DFT study

  2005cited by this paper
• Thermodynamics of A beta(1-40) amyloid fibril elongation.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• Mechanism of thioflavin T binding to amyloid fibrils.

  2005cited by this paper
• Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

  2005cited by this paper
• Multiple ligand binding sites on A beta(1-40) fibrils.

  2005influential reference
• Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

  2005cited by this paper
• Delineation of Positron Emission Tomography Imaging Agent Binding Sites on β-Amyloid Peptide Fibrils*

  2005influential reference
• Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils*

  2005cited by this paper
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo*

  2005cited by this paper
• Thermodynamics of Aβ(1−40) Amyloid Fibril Elongation†

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

  2005cited by this paper
• Annular Oligomeric Amyloid Intermediates Observed by in Situ Atomic Force Microscopy*

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

  2004cited by this paper
• Kinetic control of dimer structure formation in amyloid fibrillogenesis.

  2004cited by this paper
• Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease

  2004cited by this paper
• Imaging β-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain

  2004cited by this paper
• A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114

  2003cited by this paper
• Dissecting the Assembly of Aβ16–22 Amyloid Peptides into Antiparallel β Sheets

  2003cited by this paper
• Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

  2003cited by this paper
• Stereoselective Interactions of Peptide Inhibitors with the β-Amyloid Peptide*

  2003cited by this paper

• A Smart Dicyano-Based Fluorescent Probe for In Vivo Amyloid-β Visualization to Illuminate Alzheimer's Disease.

  2026cites this paper
• Magnetic graphene-based ferrite nanoparticles: synthesis, characterization, and anti-proliferative activity against some human cancer cells (in vitro study)

  2026cites this paper
• Rational Design of Long-Circulating Bright Fluorescent Probe for In Vivo Imaging of Amyloid-β Plaques in Alzheimer's Disease.

  2025cites this paper
• Bacterial Amyloids as Hubs for Nucleic Acid Interactions: Implications and Mechanisms

  2025cites this paper
• Thioflavin T: induced circular dichroism and density functional theory as promising approach in amyloid fibril assays

  2025cites this paper
• Targeting phagocytosis for amyloid-β clearance: implications of morphology remodeling and microglia activation probed by bifunctional chimaeras

  2025cites this paper
• Structural insights into the role of reduced cysteine residues in SOD1 amyloid filament formation

  2025cites this paper
• Investigation of protective effects of olanzapine on impaired learning and memory using behavioral tests in a rat model of Alzheimer’s disease

  2025cites this paper
• Assessing amyloid fibrils and amorphous aggregates: A review.

  2025cites this paper
• De novo design of peptides that bind specific conformers of α-synuclein

  2024cites this paper
• C9‐Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α‐Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration

  2024cites this paper
• Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

  2024cites this paper
• Feasibility of micro-organisms in soil bioremediation and dust control

  2024cites this paper
• Development of fluorophores for the detection of oligomeric aggregates of amyloidogenic proteins found in neurodegenerative diseases

  2023cites this paper
• Thiophene‐Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic‐Disease‐Associated Protein Aggregates

  2023cites this paper
• Learning and Memory Impairment Induced by Amyloid Beta Peptide and Effects of Thymol on Hippocampal Synaptic Plasticity in Rats Fed a High-Fat Diet That Received Amyloid Beta

  2023cites this paper
• Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

  2023cites this paper
• Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [18F]Flotaza, [125I]IBETA, [124/125I]IPPI and Immunohistochemistry Analysis Using QuPath

  2023cites this paper
• De novo Design of Peptides that Bind Specific Conformers of α-Synuclein

  2023cites this paper
• Monitoring α-synuclein aggregation

  2023cites this paper
• Oxidative Damages on the Alzheimer’s Related-Aβ Peptide Alters Its Ability to Assemble

  2023cites this paper
• Aspartic Acid-Assisted Size-Controllable Synthesis of Nanoscale Spherical Covalent Organic Frameworks with Chiral Interfaces for Inhibiting Amyloid-β Fibrillation.

  2022cites this paper
• Benzo[ g ] coumarin‐benzothiazole hybrid: A fluorescent probe for the detection of amyloid‐beta aggregates

  2022cites this paper
• Methodological advances and strategies for high resolution structure determination of cellular protein aggregates

  2022influential citation
• Evaluation of Amyloid Inhibitor Efficiency to Block Bacterial Survival.

  2022cites this paper
• Inhibition of Amyloid Protein Aggregation Using Selected Peptidomimetics

  2022cites this paper
• Increased Diagnostic Specificity of Congo Red Stain for Amyloid.

  2022cites this paper
• Amyloidogenesis: What Do We Know So Far?

  2022cites this paper
• Comparative Analysis of Thioflavin T and other Fluorescent Dyes for Fluorescent Staining of Bacillus subtilis Vegetative Cell, Sporulating Cell, and Mature Spore.

  2022cites this paper
• Promoted Aggregation of Aβ on Lipid Bilayers in an Open Flowing System.

  2021cites this paper
• Derivatizing merocyanine dyes to balance their polarity and viscosity sensitivities for protein aggregation detection.

  2021cites this paper
• Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence.

  2021cites this paper
• Illuminating Protein Phase Separation: Reviewing Aggregation-Induced Emission, Fluorescent Molecular Rotor and Solvatochromic Fluorophore based Probes.

  2021cites this paper
• Non-conventional photoactive transition metal complexes that mediated sensing and inhibition of amyloidogenic aggregates

  2021cites this paper
• Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease.

  2021cites this paper
• Concentration-dependent interactions of amphiphilic PiB- derivative metal complexes with amyloid peptides Aβ and amylin.

  2020cites this paper
• The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease

  2020cites this paper
• Current Methods and Future Research in the Diagnosis of Alzheimer’s Disease

  2020cites this paper
• Novel self-replicating α-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons

  2020cites this paper
• Emergence of stealth polymorphs that escape α-synuclein amyloid monitoring, take over and acutely spread in neurons

  2020cites this paper
• N‐Methylated Analogs of hIAPP Fragments 18–22, 23–27, 33–37 Inhibit Aggregation of the Amyloidogenic Core of the Hormone

  2020cites this paper
• [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis

  2019cites this paper
• Bacterial Amyloids

  2019cites this paper
• Interrogating Amyloid Aggregates using Fluorescent Probes.

  2019cites this paper
• A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils

  2019cites this paper
• Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc03042e

  2019cites this paper
• Small Molecule Induced Toxic Human-IAPP Species Characterized by NMR

  2019cites this paper
• Study on the Materials Formed by Self‐Assembling Hydrophobic, Aromatic Peptides Dedicated to Be Used for Regenerative Medicine

  2019cites this paper
• Hydrophobicity and aggregation, but not glycation, are key determinants for uptake of thermally processed β-lactoglobulin by THP-1 macrophages.

  2019cites this paper
• Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates.

  2019cites this paper
• Search for New Aggregable Fragments of Human Insulin

  2019cites this paper
• Battacin-Inspired Ultrashort Peptides: Nanostructure Analysis and Antimicrobial Activity.

  2019cites this paper
• Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.

  2019cites this paper
• Fibrous Aggregates of Short Peptides Containing Two Distinct Aromatic Amino Acid Residues

  2019cites this paper
• Insulin Hot-Spot Analogs Formed with N-Methylated Amino Acid Residues Inhibit Aggregation of Native Hormone

  2019cites this paper
• Stabilization of a Membrane-Associated Amyloid-β Oligomer for Its Validation in Alzheimer's Disease

  2018cites this paper
• In Vitro Approaches for Studying Amyloids and Neurotoxicity

  2018cites this paper
• Recombinant expression of Proteorhodopsin and biofilm regulators in Escherichia coli for nanoparticle binding and removal in a wastewater treatment model

  2018cites this paper
• Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis

  2018cites this paper
• Techniques to Analyze sRNA Protein Cofactor Self-Assembly In Vitro.

  2018cites this paper
• Serum and Urine Thioflavin-T–Enhanced Fluorescence in Severe Preeclampsia

  2018cites this paper
• Search for Fibrous Aggregates Potentially Useful in Regenerative Medicine Formed under Physiological Conditions by Self-Assembling Short Peptides Containing Two Identical Aromatic Amino Acid Residues

  2018cites this paper
• Exploring and controlling the supramolecular assembly of amyloid-forming peptides and proteins with chemical model systems

  2018cites this paper
• Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease

  2018cites this paper
• Repurposing Triphenylmethane Dyes to Bind to Trimers Derived from Aβ.

  2018cites this paper
• Time dependence of NMR observables reveals salient differences in the accumulation of early aggregated species between human islet amyloid polypeptide and amyloid-β.

  2018cites this paper
• Translational opportunities for amyloid-targeting fluorophores.

  2018cites this paper
• Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.

  2018cites this paper
• Congo Red and amyloids: history and relationship

  2018cites this paper
• Semisynthetic prion protein (PrP) variants carrying glycan mimics at position 181 and 197 do not form fibrils† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc02719b Click here for additional data file.

  2017cites this paper
• Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

  2017cites this paper
• Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide*

  2017cites this paper
• Crossroad Intermediates as ‘Folding Pathway’ Control Mechanism of Gene Expression

  2017cites this paper
• Recent Studies on Mechanisms of New Drug Candidates for Alzheimer’s Disease Interacting with Amyloid-β Protofibrils Using Molecular Dynamics Simulations

  2017cites this paper
• Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain

  2017cites this paper
• Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting.

  2017cites this paper
• Fluorescent dyes in the context of DNA-binding: The case of Thioflavin T

  2017cites this paper
• Kinetic Mechanism of Thioflavin T Binding onto the Amyloid Fibril of Hen Egg White Lysozyme.

  2017cites this paper
• Binding of Thioflavin T and Related Probes to Polymorphic Models of Amyloid-β Fibrils.

  2017cites this paper
• Inhibition of amyloid peptide fibril formation by gold-sulfur complexes.

  2017cites this paper
• Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.

  2016cites this paper
• What amyloid ligands can tell us about molecular polymorphism and disease.

  2016cites this paper
• Specific self-monitoring of metal-associated amyloid-β peptide disaggregation by a fluorescent chelator.

  2016cites this paper
• The quest for the shortest fragments of A (13-19) and B (12-17) responsible for the aggregation of human insulin.

  2016cites this paper
• Structural differences between amyloid beta oligomers.

  2016cites this paper
• A novel nano-optical sensing approach for real-time amyloid aggregation monitoring

  2016cites this paper
• Roles of DMSO-type ruthenium complexes in disaggregation of prion neuropeptide PrP106–126

  2016cites this paper
• Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting

  2016cites this paper
• A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease

  2016cites this paper
• Mitogen and Morphogen Signaling Dysregulation: Pathophysiological Influence in Pancreatic Cancer and Alzheimer’s Disease

  2016cites this paper
• Quantitative Aspects of Electrochemical Detection of Amyloid‐β Aggregation

  2016cites this paper
• Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease.

  2016cites this paper
• Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models.

  2015cites this paper
• Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis

  2015cites this paper
• New insight into the structure and function of Hfq C-terminus

  2015cites this paper
• Pre-amyloid oligomers of the proteotoxic RepA-WH1 prionoid assemble at the bacterial nucleoid

  2015cites this paper
• Structural Basis for Host Membrane Remodeling Induced by Protein 2B of Hepatitis A Virus

  2015cites this paper
• Quantification of [11C]PIB PET for Imaging Myelin in the Human Brain: A Test—Retest Reproducibility Study in High-Resolution Research Tomography

  2015cites this paper
• Adsorption and sub-nanomolar sensing of thioflavin T on colloidal gold nanoparticles, silver nanoparticles and silver-coated films studied using surface-enhanced Raman scattering.

  2015cites this paper
• The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease

  2015cites this paper